O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.15B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$186M
2
+$115M
3
+$60.8M
4
ABBV icon
AbbVie
ABBV
+$53.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.4M

Top Sells

1
+$83.2M
2
+$60M
3
+$58.4M
4
UNH icon
UnitedHealth
UNH
+$56.5M
5
CELG
Celgene Corp
CELG
+$53.8M

Sector Composition

1 Healthcare 86.06%
2 Technology 0.09%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$11.3M 0.14%
160,000
-95,000
77
$11.3M 0.14%
4,628,500
78
$11.2M 0.14%
3,213,900
-1,378,100
79
$10.4M 0.13%
1
80
$10.2M 0.13%
2,888,000
-6,501,000
81
$9.85M 0.12%
143,000
82
$9.4M 0.12%
801,700
+99,100
83
$9.22M 0.11%
111,100
-18,900
84
$8.9M 0.11%
+632
85
$8.67M 0.11%
94,000
-45,000
86
$8.36M 0.1%
102,000
-689,000
87
$7.93M 0.1%
+5,714
88
$7.51M 0.09%
462,400
-527,600
89
$7.31M 0.09%
447,500
90
$6.75M 0.08%
692,900
-9,100
91
$6.7M 0.08%
174,000
-131,000
92
$6.58M 0.08%
90,000
93
$6.57M 0.08%
+22,311
94
$6.55M 0.08%
63,000
+4,000
95
$6.4M 0.08%
221,000
-58,000
96
$6M 0.07%
+600,000
97
$5.67M 0.07%
95,500
-224,700
98
$5.5M 0.07%
19,501
99
$5.19M 0.06%
80,000
100
$5.18M 0.06%
580,000
2 3
4
5 6